Bladder cancer is the sixth most prevalent malignancy in the United States. The standard treatment for advanced bladder cancer involves radical cystectomy (RC), which is plagued by high rates of complications and mortality in part due to infection and rapid skeletal muscle wasting. Poor nutritional status is associated with higher complications rates following RC.